-
-
-
-
-
-
-
uniQure reports sustained enzyme activity in Fabry disease gene therapy trial
-
-
-
-
-
-
-
Denali shares clinical data on enzyme treatments for rare diseases
-
-
-
-
-
-
-
IMUNON restructures operations to focus on phase 3 ovarian cancer trial
-
-
-
-
-
-
-
NorthStrive extends AI drug discovery Phase III timeline to Q2 2026
-
-
-
-
-
-
-
Evogene subsidiary licenses cancer drug BMC128 to Shanghai Lishan
-
-
-
-
-
-
-
Immunic presents CALLIPER trial data at ACTRIMS forum
-
-
-
-
-
-
-
Nanox receives FDA clearance for TAP2D imaging enhancement capability
-
73,934 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.

